Update on hypnotherapy for psychiatrists

2021 ◽  
pp. 1-7
Author(s):  
Natalie A. Chan ◽  
Zhisong Zhang ◽  
Guoxing Yin ◽  
Zhimeng Li ◽  
Roger C. Ho
Keyword(s):  
Psychiatric Disorders ◽  
Practice Guidelines ◽  
Review Article ◽  
Outcome Studies ◽  
Evidence Based ◽  
High Quality ◽  
Long Time ◽  
Meta Analyses ◽  
Evidence Based Therapy

SUMMARY Although hypnosis has played a part in psychotherapy for a long time, it is not yet seen as an evidence-based therapy and is absent from many practice guidelines when it comes to the treatment of psychiatric disorders. At present, the applications and methods of hypnotherapy are poorly understood and other methods of psychotherapy tend to be favoured. This review article aims to introduce the role of hypnotherapy and its application for certain common psychiatric presentations, as well as examine its efficacy by summarising recent evidence from high-quality outcome studies and meta-analyses.

Evidence-based approaches to psychiatry

2017 ◽  
pp. 119-134
Author(s):  
Paul Harrison ◽  
Philip Cowen ◽  
Tom Burns ◽  
Mina Fazel
Keyword(s):  
Patient Experience ◽  
Meta Analysis ◽  
Psychiatric Research ◽  
Evidence Based ◽  
High Quality ◽  
Qualitative Methodologies ◽  
Meta Analyses ◽  
Based Medicine ◽  
Quality Evidence

‘Evidence-based approaches to psychiatry’ describes the application of evidence-based medicine (EBM) to psychiatric practice. The chapter covers the key processes in EBM, including the formulation of a clinically relevant question, the systematic search for high-quality evidence and the meta-analytic synthesis of data. It demonstrates how evidence-based approaches to psychiatry have led to important developments showing quantitative effects of different treatments through advanced meta-analysis of data from randomized trials. This has underpinned the development of clinical guidelines that have the aim of improving the reliability and quality of treatments that patients receive. The chapter also describes how meta-analyses should be critically reviewed, as well as their problems and limitations. Not all relevant questions in psychiatric research are susceptible to the quantitative approach offered by EBM, and the chapter also outlines how qualitative methodologies can play a key role in answering important questions related, for example, to the patient experience.

Methodological, Theoretical, Infrastructural, and Design Issues in Conducting Good Outcome Studies

2011 ◽  
Vol 21 (6) ◽  
pp. 644-653 ◽  
Author(s):  
Michael P. Kelly ◽  
Tessa A. Moore
Keyword(s):  
Best Practice ◽  
Outcome Studies ◽  
Controlled Trials ◽  
Evidence Based ◽  
Good Outcome ◽  
Randomized Controlled ◽  
Causal Pathways ◽  
Causal Pathway ◽  
Based Medicine

This article outlines a set of methodological, theoretical, and other issues relating to the conduct of good outcome studies. The article begins by considering the contribution of evidence-based medicine to the methodology of outcome research. The lessons which can be applied in outcome studies in nonmedical settings are described. The article then examines the role of causal pathways between interventions and outcomes and especially the importance of delineating them in advance of undertaking investigations. The development of designs based on randomized controlled trials (RCTs) with fully articulated causal pathways is described. Ways of supplementing RCTs with methods to highlight elements in the causal pathway in outcome studies are indicated. The importance of adhering to best practice in reporting and analysis is also noted.

The role of evidence-based therapy relationships on treatment outcome for adults with trauma: A systematic review

2017 ◽  
Vol 19 (2) ◽  
pp. 185-213 ◽  
Author(s):  
Amy E. Ellis ◽  
Vanessa Simiola ◽  
Laura Brown ◽  
Christine Courtois ◽  
Joan M. Cook
Keyword(s):  
Systematic Review ◽  
Treatment Outcome ◽  
Evidence Based ◽  
Evidence Based Therapy

Antipsychotics in Dementia

2017 ◽  
Vol 41 (S1) ◽  
pp. S662-S663
Author(s):  
A. Poças ◽  
S. Almeida
Keyword(s):  
Antipsychotic Medication ◽  
Practice Guidelines ◽  
Older Patients ◽  
American Psychiatric Association ◽  
Clinical Care ◽  
Behavioral Symptoms ◽  
Evidence Based ◽  
Susceptible Population ◽  
Long Time ◽  
Competing Interest

Behaviour disorders and psychosis may represent a greater challenge in patients with dementia. There are evidence-based recommendations to assess psychological and behavioral symptoms of dementia and the practice guidelines of American psychiatric association (APA) reinforce general principles of good clinical care. However, when these patients initiate a psychotropic, the agents often continue to be prescribed for a long time, even after the symptoms disappeared. The recommendation of reduce/stop an antipsychotic medication within 4 months of initiation may seem counterintuitive when the patient is better, with remission of the original symptoms. However, the studies showed that a large amount of patients with dementia can discontinue antipsychotic medication without a return of agitation or psychosis. Older patients are a particularly susceptible population and the risk/benefit of any medication should be carefully considered. For most patients the risk of harm outweighs the profits of continuing treatment and we need a routine evaluation of this factor to identify these cases.It's important to reduce unnecessary medications but agitation and psychosis associated with severe distress also carry serious risks; discontinuing these medications can be dangerous so we need to manage it with caution evaluating each case as an individual one.Disclosure of interestThe authors have not supplied their declaration of competing interest.

scholarly journals Chemerin and Cancer

2019 ◽  
Vol 20 (15) ◽  
pp. 3750 ◽  
Author(s):  
Oliver Treeck ◽  
Christa Buechler ◽  
Olaf Ortmann
Keyword(s):  
Review Article ◽  
Innate Immune ◽  
Original Research ◽  
Cellular Receptors ◽  
Dna Microarray Data ◽  
Tumor Tissues ◽  
Pubmed Database ◽  
Meta Analyses ◽  
G Protein Coupled

Chemerin is a multifunctional adipokine with established roles in inflammation, adipogenesis and glucose homeostasis. Increasing evidence suggest an important function of chemerin in cancer. Chemerin’s main cellular receptors, chemokine-like receptor 1 (CMKLR1), G-protein coupled receptor 1 (GPR1) and C-C chemokine receptor-like 2 (CCRL2) are expressed in most normal and tumor tissues. Chemerin’s role in cancer is considered controversial, since it is able to exert both anti-tumoral and tumor-promoting effects, which are mediated by different mechanisms like recruiting innate immune defenses or activation of endothelial angiogenesis. For this review article, original research articles on the role of chemerin and its receptors in cancer were considered, which are listed in the PubMed database. Additionally, we included meta-analyses of publicly accessible DNA microarray data to elucidate the association of expression of chemerin and its receptors in tumor tissues with patients’ survival.

scholarly journals Impact of Mobile Phone Usage on Some Health Aspects of Children and Adolescents: Evidence Based Review Article

2019 ◽  
Vol 5 (4) ◽  
pp. 159-161
Author(s):  
Aqeel Abbas Noaman ◽  
Keyword(s):  
Mobile Phone ◽  
Mobile Phones ◽  
Review Article ◽  
Evidence Based ◽  
Radio Waves ◽  
Quality Of Sleep ◽  
Long Time ◽  
Mobile Phone Usage ◽  
The Brain

The Wi-Fi devices in mobile phones have a key role in exchanging information and data to show images, audios, videos, and to transfer applications from mobile emitting radio waves. These waves emitted by mobile devices are radiofrequency waves, where many kinds of researches in this field have shown that they negatively affect, especially when using the mobile phone for a long time during the day on the vision and the level of hearing in the young people, as well as the effect on the nervous system caused Headache and muscle aches, as well, it has also been derived from these researches and studies that these waves can cause more depression or psychological stress in children and young users of mobile phones. Moreover, it can cause damage to the brain cells and may have caused a brain tumor even though many studies have not proved it. Also, these studies, which were presented in this article, have concluded that the use of mobile phones, especially late at night, can negatively affect the quality of sleep.

Sign in / Sign up

Export Citation Format

Share Document